Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Details : Under the terms of Agreement, NovaRock has granted Flame Biosciences exclusive rights to NBL-015 outside of Greater China. Flame shall be responsible for the development, regulatory approval, and commercialization of NBL-015.
Product Name : NBL-015
Product Type : Antibody
Upfront Cash : $7.5 million
August 23, 2021
Reset All
